25 domains drive half of all AI brand recommendations in supplements. Most aren't what you think.

Headline findings

• 25 domains generate 50% of all 1,329 brand citations across the 5 AI platforms. 99 domains generate 80%. Past domain #100, citations scatter across long-tail sources that move nothing.
• Brands carrying third-party testing certification (NSF, USP, Informed Sport, Clean Label Project, ConsumerLab) surface roughly 30% more often than non-certified peers on commercial-intent prompts. Certification is the single strongest correlate of inclusion in trust-cert AI responses.
• 22% of (prompt × platform) combinations returned zero brand recommendations. Persona-led, safety-led, and ingredient-led queries collapse to ingredient discussion or expert quotes instead of named brands.
• Perimenopause queries surfaced 6 unique brands across 15 outputs. Pregnancy queries surfaced 51 unique brands across the same volume. The default “AI's perimenopause supplement” is structurally unclaimed.

Six more findings follow below — covering channel-locked brand identity, the 12–18 month window in emerging categories, the structural Gemini-vs-ChatGPT difference, negative-memory persistence, Reddit's rise as an AI source, and the niche-vs-universal pattern in cross-platform consensus. For each, we cover what it means concretely for content strategy and external-presence work, so you can align the two and surface your brand in the queries that matter for your category.

Methodology

We want to be transparent about what we did, because the findings only matter if the methodology holds up.

Dataset. 47 prompts × 5 platforms = 235 query outputs, collected April 2026. The 47 prompts cover six commercial angles: brand-first and comparison queries, persona-targeted queries, worst/reputation queries, trending 2026 categories, channel-specific queries, and lifestyle/diet alignment.

Platforms. ChatGPT (gpt-5-search-api), Claude (claude-sonnet-4-6), Gemini (gemini-2.5-flash with Google Search grounding), Perplexity (sonar), plus a search-engine baseline collected via Search API (top SERP results extracted as brand-mention source). All collection ran via official APIs with web search or grounding tools enabled. We chose API access over scraped logged-out sessions because API responses are reproducible and the documented industry standard for at-scale measurement.

Brand extraction. Four parallel extraction agents read each raw response and pulled brand names against a strict guide. Trademarked compounds (KSM-66, Cognizin®, SunActive Fe, Ferrochel®, Verisol®) are NOT counted as brands — these are patented ingredients used inside multiple consumer brands' formulations. We also captured every cited URL, mapped each to its registered domain, and counted citation frequency per platform per brand.

What we measured per output. For each (prompt × platform) combination, we extracted: number of distinct brands named, position of each brand in the response (first-named to last), explicit recommendations versus warnings or “what to avoid”, cited source URLs, and meta-data signals (whether the response cited studies, named experts, or refused to name brands at all).

High-level limitations apply (single timestamp, English-language only, five platforms rather than eight); the full Limitations section appears at the end of this article.

Finding 1: 25 domains drive half of every brand citation

The 1,329 brand citations we collected come from 275 distinct source domains. Citation share concentrates fast and then flattens. Two domains alone (healthline.com and fortune.com) account for 11% of all citations: 149 of 1,329. The next five together push the cumulative total to 25%. By domain #25, we hit 50%. By domain #99, we hit 80%. Past that, marginal citation share drops below 0.4% per domain.

Most supplement marketing teams aim for Healthline placement. Healthline is the single largest gatekeeper at 18% of all citations. But the 25-domain group below it includes domains most outreach plans miss entirely.

Mid-tier domains that actually move citation share:

• consumerlab.com — 56 citations across 4 platforms. Notably, ChatGPT does NOT cite ConsumerLab — its content sits behind a paywall. The implication for paid-content publishers is direct: gating cuts you out of a major AI engine entirely.
• innerbody.com — 43 citations across all 5 platforms, anchored by emerging-category review pages (best NAD+, best NMN, best urolithin A, best berberine).
• eunatural.com — 34 citations from a single article, “best supplement brands 2026”, published on a brand-owned blog. One page, four platforms.
• naturproscientific.com — 33 citations from a single “bad-supplements-list” article. One page is a major gatekeeper for negative queries.
• livemomentous.com — 28 citations across 4 platforms. A brand-owned blog (Momentous is a supplement brand) ranking as an authority source. Their berberine roundup alone drove 13 citations.
• factually.co, supplementchecker.co — fact-check authorities ChatGPT and Claude trust for trust-cert and “third-party tested” queries.
• reddit.com — 12 citations across 3 platforms, growing.
• youtube.com — 13 citations, but only on Perplexity. Perplexity uniquely treats video as a source.

What this means. Most outreach plans optimize for one or two top domains and assume the rest is noise. The data says the top 25 domains carry the cumulative weight, and a meaningful slice of that weight comes from domains that almost no one targets: brand-owned blogs (livemomentous, omre), fact-check sites (factually, supplementchecker), single-article gatekeepers (eunatural, naturproscientific), and platform-exclusive sources (youtube on Perplexity, reddit on the search-engine baseline and ChatGPT). A 6-month outreach plan against 25 domains will move more brand citation share than the same effort spent on Healthline plus a long tail.

A second implication, more strategic: brand-owned blog content is a real lever. Two of the 25 domains carrying meaningful citation share are owned by supplement brands. Both rank because they published genuinely useful category roundup content with citations of their own — not because the brand outranked itself. The model is replicable.

Finding 2: Third-party testing certification raises brand mention rates 30%+

A consistent pattern across the 47 prompts: brands carrying explicit third-party testing certification (NSF, USP, Informed Sport, Clean Label Project, ConsumerLab seal) appear in commercial-intent AI responses at a noticeably higher rate than non-certified peers. Looking at the brand-summary data, brands without verifiable third-party-testing references rank roughly 30% lower in mention frequency on prompts where AI is asked for “trustworthy”, “third-party tested”, or “certified” supplement brands. On the trust-cert prompt block specifically, certification was the single strongest correlate of inclusion in the AI response.

The pattern is most visible in women-focused brands. Clean Label Project certification specifically lifts Ritual, MaryRuth's, Pink Stork, HUM Nutrition, and SmartyPants — all of which surface across multiple platforms in trust-cert prompts. NSF certification carries similar weight for Thorne and Pure Encapsulations on practitioner-grade prompts. USP certification surfaces Nature Made on mass-market multivitamin prompts.

This finding has a direct content-strategy correlate. AI cites publishers that name testing protocols (consumerlab.com, supplementchecker.co, factually.co are all in the top 25 domains). For a brand, the move is twofold: (1) earn the certification first, then (2) make sure the certification is documented on the brand-owned domain in extractable, AI-friendly content (named test, named lab, dated certificate). Without that on-site documentation, even certified brands underperform their certification because AI cannot find the proof on the brand's own pages.

Finding 3: 22% of supplement queries return zero brand recommendations

Across 235 (prompt × platform) combinations, 51 returned zero brand mentions despite the user explicitly asking for “best supplements for X”. The pattern clusters in three places:

• Persona-targeted health prompts — perimenopause, breastfeeding, marathon training, postpartum recovery. ChatGPT, Claude, and Gemini routinely refuse to name brands and default to ingredient education or expert quotes.
• Safety questions — “is creatine safe for women”, “is ashwagandha safe long-term”. The four LLMs return zero brands on most safety phrasings; the search-engine baseline still surfaces brand-mentioning articles because consumer-review and best-of listicles rank for these queries.
• Ingredient-led prompts — adaptogens, longevity, brain fog, NMN, NAD+. All four LLMs default to ingredient discussion (best form of magnesium, best dosing) instead of named brands.

Average brand count per (prompt × platform) breaks the pattern down sharply by prompt type:

The pattern is direct. When the prompt explicitly asks for “brands”, “companies”, or specific channels, AI returns brand names. When the prompt asks about a health goal, ingredient, or safety concern, AI returns ingredient education, expert quotes, or study summaries instead. AI is reading the question literally. A user asking for “supplements for perimenopause” is asking about the supplement category; AI delivers category education. A user asking for “best magnesium brand for sleep” is asking about brands; AI delivers brand names.

When AI returns zero brands, it substitutes one of three things: ingredient discussion (most common), peer-reviewed study summaries, or expert authority quotes. ChatGPT on creatine safety cites five studies and zero brands. Some platforms cite expert authorities directly (Dr Mary Claire Haver on perimenopause, Dr Jolene Brighten on women's hormones) without naming products.

What this means. AEO strategy here is not just about phrasing more brand-extractable prompts. It is about producing the kind of content AI substitutes-in when it refuses to name brands, with brand identity embedded inside the evidence. Three concrete content moves emerge from this finding:

1. Build ingredient-authority content on the brand-owned domain. When AI substitutes “Brand X melatonin” with “magnesium glycinate is the best form for sleep”, the question becomes which authority AI cites for that ingredient claim. Brand-owned blogs with depth on ingredient science (livemomentous, omre.co in our data) rank as authority sources alongside publishers. The brand name appears inline in the citation context, not as a recommendation but as a source.
2. Publish content that answers persona and safety questions directly, with the brand placed as the credible source of evidence. A perimenopause supplement brand should publish “what magnesium form works for menopause hot flashes” with brand-specific clinical data woven through. AI substitutes ingredient education for brand recommendation, and if the substitute is the brand's own evidence, the brand is named structurally rather than as a product pitch.
3. For symptom and safety prompts, target the cited expert/publisher network. When ChatGPT cites Dr Mary Claire Haver on perimenopause without products, the goal becomes “appear in a Dr Haver context” — partnership, podcast feature, peer-reviewed study collaboration. The brand doesn't go through ChatGPT directly; it goes through the expert ChatGPT trusts.

Finding 4: The perimenopause vacuum — 6 brands for a fast-growing market

To make the persona-empty-quadrant finding concrete, here is total brand-mention volume across 5 platforms × 3 prompts per persona:

Eight total brand mentions across 15 outputs (3 prompts × 5 platforms). An average of 0.5 brands per output. Six unique brands across the entire persona block: Thorne Meta-Balance, HUM Nutrition Fan Club, Thorne Hormone Advantage, Estroven, New Chapter Magnesium + Ashwagandha, and one more single-mention entry. Two of the six are existing Thorne product extensions. One is a legacy brand owned by Pfizer (Estroven). The remaining brands appear once each.

For comparison: pregnancy/postpartum has 8.75x more brand mentions and 8.5x more unique brands competing for visibility. Endurance athlete has 7x. Biohacker/longevity has 6x.

The perimenopause supplement market is one of the fastest-growing health verticals globally, driven by demographic shifts. AI's default-recommendation slot for that market is structurally unclaimed. Any brand investing in citation-worthy perimenopause content over the next 6–12 months has a realistic chance of becoming AI's default — the competition is much weaker than in pregnancy, longevity, or athlete categories.

Finding 5: NMN, NAD+, urolithin A, apigenin — categories with open default slots

These are 12–18-month-old supplement categories where AI's default brand consensus is still forming:

In each of these categories, the top-named brand is a 3–5-year-old DTC startup. Legacy supplement brands are largely invisible. The window of opportunity is 12–18 months: after that window closes, as it has for collagen, omega-3, and magnesium, entry cost rises 5–10x because AI's default associations are locked in.

A brand launching a credible product in any of these categories now can plausibly become AI's default for the category by mid-2027. After 2028, the same effort produces a fraction of the visibility return.

Finding 6: Reddit grew 5x as an AI source

In an earlier 15-prompt sample, Reddit appeared in 2–3 brand citations. In this 47-prompt sample, Reddit appears in 12, a 5x increase, ranking it #22 by total citations as a domain. Reddit-driven citations cluster around iron supplement choices (r/GenXWomen, r/Supplements), berberine for weight loss (r/A1HealthReviews), gluten-free supplements (r/glutenfree), ashwagandha brand reviews (r/PeterAttia), and pharmacy professional opinions on r/pharmacy (including the well-known “Doublewood is shady” thread).

Reddit is now a structural AI source for supplements. Negative Reddit threads about a brand surface in AI responses for years. Brand monitoring against Reddit threads is a new vector — not an SEO concern, an AEO concern.

Finding 7: Gemini names 12.5 brands per prompt. ChatGPT names 5.6.

Per-platform behavior holds at scale. Across 47 prompts:

The Gemini-vs-ChatGPT spread (2.2x) is structural, not sample artifact. A brand optimizing for ChatGPT visibility is targeting a platform that names ~45% as many brands per response as Gemini. The platforms' anti-rec coverage also differs: Claude flags “what to avoid” in 100% of its 47 responses, Gemini in 77%, Perplexity in 53%. The implication for content strategy is that Claude-targeted optimization should account for “what to avoid” framing in every category.

Finding 8: Negative AI memory persists for years across multiple query phrasings

The 5 worst/reputation prompts (worst supplement brands, FDA warnings, mislabeling, supplements that don't work, dangerous to avoid) generated 202 warning rows across 65+ unique brands. The most AEO-relevant pattern is structural: AI memory keeps negative signals alive long after the original news cycle ends, and a single negative event surfaces in multiple separate query phrasings.

Concrete example from the data: the 2015 New York Attorney General investigation into supplement mislabeling at GNC and Walmart still surfaces in 2026 ChatGPT and Claude responses to “worst supplement brands”. Eleven years after the original news cycle, the brand-event association is still cited.

The same brand can appear in multiple separate negative-prompt phrasings. We counted how many of the 5 negative prompts each brand surfaces in:

A single FDA action surfaces across “worst”, “dangerous”, “FDA recall”, “mislabeling”, and “don't work” phrasings. One event becomes 4–5 surface attacks instead of one.

A second pattern is cluster contamination. AI groups brands by event type and pulls neighbors down with them. The April 2026 diclofenac FDA action contaminated 10 brands together (Curcuflex, DINA, Dolotrex, Flexi Bion, Kuka Flex CBD, RM Joe, ULTRA ADVANC3, ULTRA ADVANC3 GOLD, Umary, Yeicob). The Vitaquest International iron-supplement child-resistant-packaging recall pulled 16 brands into the same negative cluster — most of which used Vitaquest as a contract manufacturer rather than failing themselves.

What this means for brands with legacy reputation issues. A 2018–2024 lawsuit or FDA action attached to a brand requires defensive content on the brand's owned domain: a transparency timeline page that AI can find and cite as positive context. Without it, AI surfaces only the negative source. A second move applies to brands using contract manufacturers: switching manufacturers before, not after, recalls happen, or investing in independent COA publishing on the brand's domain to differentiate from cluster siblings.

Finding 9: Only 8 brands appear on all 5 AI platforms

The strongest pattern in the dataset is that brands surface on the queries their product specifically covers. Niche specialists with narrow product lines but a strong first-position win on the matching query show up clearly:

• Real Mushrooms 5 Defenders — first-position on the mushroom complex prompt, invisible across immunity and longevity queries.
• LMNT Zero-Sugar Electrolytes — locked on endurance-athlete queries, invisible on general electrolyte prompts.
• Theralogix TheraNatal Lactation Complete — first-position on breastfeeding-specific queries, invisible on broader prenatal queries.
• Simple Science Magnesium Complex — first-position on Gemini's “best magnesium for sleep” and “best magnesium for menopause”, invisible everywhere else.
• COMPLEMENT Essential — first-position on vegan multivitamin, invisible across general multivitamin prompts.

These brands have a viable AEO position without cross-platform consensus. They own a specific query.

A different pattern shows up at the other end of the brand spectrum: universal coverage. Of 791 unique brands AI named in the supplements category, only 8 appeared on all 5 platforms with a weighted score above 40:

These are predominantly broad-category brands. Thorne wins prenatal, melatonin, third-party-tested, electrolytes, and multivitamin queries simultaneously. Pure Encapsulations spans practitioner-grade categories. Garden of Life and Nature Made carry mass-market multivitamin breadth. The pattern is consistent: cross-platform consensus correlates with category breadth, not niche depth.

Many supplement brands deliberately focus on a single sub-category — one ingredient, one persona, one product line. Cross-platform consensus is not an automatic goal for those brands; it is a side effect of category breadth. Optimizing for visibility on every platform simultaneously is an exception, not the default. The realistic target for most brands is winning on the platforms and queries where their product actually competes.

Finding 10: 0 brands span all 3 retail-channel queries

Three prompts asked AI for supplement recommendations specific to retail context: “best supplements at Costco”, “best supplements on Amazon”, and “best subscription supplement services”. Across all 5 platforms, 0 brands appeared in all three channel prompts simultaneously.

87% of brands AI associates with retail channels are locked to a single context. The pattern is sharp:

• Costco-locked: Kirkland Signature, Pure Alaska Omega, Nature's Bounty, Further Food, Nature's Lab Gold. Premium DTC brands (Thorne, Transparent Labs) are absent from Costco prompts.
• Amazon-locked: NOW Foods, Centrum, Bronson Vitamins, Double Wood Supplements, Amazon Basics, Amazon Elements. Practitioner-only brands (Pure Encapsulations, Designs for Health) are absent from Amazon prompts.
• Subscription-locked: HUM Nutrition (5/5 platforms), Persona Nutrition, Ritual, Perelel, VitaminLab, Bioniq, Rootine, Future Kind. Mass-market brands are absent.

The most striking cases are brands that physically sell across all three channels but appear in only one AI context:

• NOW Foods has the same product line on Amazon and through subscription services. AI mentions it only in Amazon context.
• Thorne is a top-3 brand overall, sold practitioner-direct, on Amazon, and via subscriptions. In channel queries, AI places Thorne only in subscription context.
• Centrum is sold everywhere physically. AI mentions it only in Amazon context.

What this means. AI's brand-identity model is anchored to where the brand has editorial coverage, not where it sells. A brand selling on three channels but covered editorially on only one will appear AI-locked to that one. Channel positioning is content strategy, not retail strategy. The 8 brands that appear in 2 of 3 channel contexts are likely doing one specific thing: they have category coverage on channel-specific publishers (Costco-related listicles, Amazon Best-Sellers analyses, subscription review sites) — not on a single dominant publisher.

Hypotheses confirmed at scale

The 47-prompt sample confirmed several working hypotheses we went in with:

• Legacy brands have high mention counts but low first-position wins. Nature Made and NOW Foods are mentioned 19 and 17 times respectively, with zero first-position rankings between them. Premium DTC brands (Thorne, Transparent Labs, Momentous) take the top slots.
• Each platform has its own #1. Claude defaults to Thorne. ChatGPT defaults to Pure Encapsulations. Perplexity splits between Transparent Labs and Pure Encapsulations. Gemini lists everything. The search-engine baseline reflects whichever publisher ranks for the query.
• Size does not equal visibility. Wonderfeel Youngr NMN, a small DTC startup, scores 38 and beats Centrum and most legacy multivitamin brands.
• UK and US publishers cluster differently across platforms. UK publishers (bbcgoodfood, marieclaire.co.uk) cluster on Gemini and Perplexity. US publishers (healthline, fortune, medicalnewstoday) cluster on ChatGPT and Claude. Brand selection diverges accordingly.

Limitations

We are deliberate about what this snapshot does not prove.

• Single timestamp. April 2026 only. AI rankings shift over time; reproducibility tests across 2-week windows are scheduled for the top prompts to validate ranking stability.
• API responses, not web UI. API and UI can produce slightly different brand sets. This is the documented industry standard for at-scale measurement, but a brand auditing itself should also spot-check a logged-in UI session.
• English-language queries. International (DE, FR, ES) splits not in scope.
• Five platforms. Bing Copilot, You.com, and Mistral could extend the dataset. Cost is the only blocker.
• No correlation with sales data. AI visibility correlates with brand citation behavior in AI responses. We did not bridge this to Trustpilot ratings, sales market share, or paid traffic in this snapshot. Cross-validation against external market-share data is on the roadmap for the next iteration.

What this means for brands publishing in this space

Five concrete moves emerge directly from the data:

1. Do not over-invest in Healthline alone. Healthline is 18% of citations. The next 24 domains together are 32%. A 6-month outreach plan against the top 25 domains will move more brand visibility than the same effort spent on Healthline plus a long tail.
2. Treat each AI platform as a separate market. Each platform has its own #1 brand, and the Gemini-vs-ChatGPT spread on average brands per response is 2.2x (12.5 vs 5.6). Test per platform, optimize per platform, and accept that ChatGPT optimization does not buy Gemini optimization.
3. Reframe persona and safety prompts as brand-first prompts, but also publish content that answers them directly. A perimenopause brand should not optimize only for “best supplements for perimenopause” (67% zero-brand rate). They should optimize for “best magnesium brand for menopause” or “Thorne Meta-Balance vs HUM Fan Club” (3% zero-brand rate), AND publish persona-question content with their own brand woven in as the credible source of evidence. Both routes work; relying on only the first leaves the substitute-content slot to a competitor or publisher.
4. Audit your channel-locked AI identity. If your brand sells on Amazon, Costco, and through subscription, AI almost certainly sees you as locked to one of those contexts. The 8 brands that span 2+ channels are doing channel-specific publisher coverage. The 53 brands locked to one are not.
5. Build defensive content for any legacy negative signal. If your brand has any FDA action or lawsuit attached over the last decade, AI surfaces it. The countermove is a transparency timeline page on the brand's owned domain — not an attempt to remove the original source.

For emerging-category brands (NMN, NAD+, urolithin A, apigenin, berberine), the window of opportunity to claim AI's default slot is 12–18 months. After that, AI's default associations consolidate and entry cost rises 5–10x.